INJ treasury

INJ Treasury: Pineapple Financial Launches $100M On Wall Street

Overview Of Pineapple’s INJ Treasury Launch

Pineapple Financial Inc. (NYSE: PAPL) has announced the creation of a $100 million INJ treasury. The initiative was revealed during Sonic Summit 2025 in Singapore and marks the first time Wall Street gains access to Injective (INJ) through a publicly traded company.

Key Takeaways

  • Pineapple Financial (NYSE: PAPL) launches a $100 million INJ treasury, the first of its kind on Wall Street.
  • The move positions Pineapple as the world’s largest institutional INJ holder.
  • Institutional entry could reshape Injective’s role in tokenized assets and decentralized finance.
  • Market analysts expect stronger liquidity, volatility, and possible ETF/ETP pathways for INJ.

This allocation makes Pineapple the largest institutional holder of INJ. Backed by prominent investors including FalconX, Kraken, and Blockchain.com, the INJ treasury will be deployed gradually over the coming months to support tokenized asset adoption.


Historical Context And Market Impact Of The INJ Treasury

Injective began as a decentralized exchange protocol in 2018 and evolved into a finance-focused Layer-1 blockchain. Its ecosystem gained significant momentum in 2025, particularly after Google Cloud became a validator.

Pineapple’s INJ treasury builds on this momentum. The $100 million allocation equals around 10% of INJ’s $1 billion market cap. Such a large-scale purchase could influence price trends, liquidity, and volatility. Analysts also highlight the potential for ETF or ETP eligibility, which could channel billions of dollars in institutional capital into Injective.


Long-Term Implications Of Pineapple’s INJ Treasury

The launch represents more than a short-term market event. By 2030, Pineapple’s INJ treasury may accelerate Wall Street’s entry into altcoins, with Injective at the forefront of tokenized real-world assets. McKinsey projects the RWA market could reach $2 trillion, and Injective is now strategically positioned to capture that growth.

Over time, this treasury could encourage stronger regulatory frameworks, fuel DeFi innovation, and position INJ as a cornerstone asset bridging traditional finance and decentralized ecosystems.

Frequently Asked Questions

What did Pineapple Financial recently announce regarding Injective?
Pineapple Financial (NYSE: PAPL) launched a $100 million Injective allocation, becoming the first publicly traded company to bring INJ to Wall Street.
Why is the Injective allocation significant for Wall Street?
It marks the first time institutional investors gain direct exposure to INJ through a regulated, publicly traded company, bridging traditional finance with DeFi.
How large is Pineapple’s Injective allocation compared to the market cap?
The $100 million allocation represents about 10% of Injective’s $1 billion market capitalization, making Pineapple the largest institutional INJ holder.
What potential market impact could the Injective allocation have?
Analysts expect increased liquidity, potential price appreciation, and eligibility for ETF/ETP products, which could attract billions in institutional capital.
What are the long-term implications of this initiative?
By 2030, Pineapple’s Injective allocation could accelerate tokenized asset adoption, strengthen DeFi ecosystems, and position INJ as a cornerstone in global finance.

Leave a Comment

Your email address will not be published. Required fields are marked *